4Filed Aug 10, 8:00 PM ET

Femasys (FEMY) CFO Dov Elefant Buys $50K Stock

$FEMY · FEMASYS INC

Research Summary

AI-generated summary of this SEC filing

Updated

Femasys (FEMY) CFO Dov Elefant Buys $50K Stock

What Happened Dov Elefant, Chief Financial Officer of Femasys Inc. (FEMY), purchased 15,625 shares on Aug 7, 2026 at $3.20 per share for an aggregate $50,000. On the same date he also acquired two derivative awards (each covering 15,625 shares) structured as warrants — one a Common Warrant and one a Milestone Warrant. The equity purchase is a direct buy (P), while the other two entries are awards/grants (A) of derivative securities.

Key Details

  • Transaction date(s): Aug 7, 2026; Form 4 filed Aug 11, 2026 (appears timely).
  • Open‑market/private purchase: 15,625 shares @ $3.20 = $50,000 (footnotes F1, F4).
  • Derivative awards: two grants of 15,625 underlying shares each (warrants) (footnotes F2, F5).
  • Common Warrant: exercisable at $2.95 per share, subject to adjustment (F2); exercise also subject to Nasdaq limitations (F3).
  • Milestone Warrant: exercisable only after a Milestone Date (first date on/after Aug 10, 2027 when specified U.S. revenue and price conditions are met); expiration and exercisability timing are currently indeterminable (F5).
  • Shares owned after transaction: not disclosed in the filing.

Context

  • The purchased shares are immediate common stock ownership; the two warrant grants are rights to buy common shares in the future, not current shares. The Common Warrant has a stated exercise price ($2.95) and may be exercised subject to market rules; the Milestone Warrant depends on company performance and price conditions and is therefore speculative in timing. Purchases by executives are often viewed as a more informative (bullish) signal than sales, though filings do not state motives.